A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Therapeutic role of kaempferol and myricetin in streptozotocin induced diabetes synergistically via modulation in pancreatic amylase, glycogen storage and insulin secretion
[post]
2022
unpublished
Aim Kaempferol and Myricetin alone have promising benefits on diabetes and related complications, yet the effectiveness of cotreating the two compounds on diabetes have not been studied. The existing investigation was to study the combined anti-diabetic effect of kaempferol and myricetin in streptozotocin (STZ)-activated diabetes in rats. Methods To evaluate the antidiabetic activity, 36 Wistar rats were segregated into six groups; Normal, 50 mg/kg STZ-induced diabetes, and four (50 mg/kg
doi:10.21203/rs.3.rs-1679223/v1
fatcat:hd4jaippy5eyvnex355lfjqnaq